EGFR and head and neck squamous cell carcinoma: A recent study suggested that AXL heterodimerizes with EGFR, thereby activating YAP via the EGFR–LATS1/2 axis, a potential reason for head and neck squamous cell carcinoma (HNSCC) [65].